In MF/SS, the pathologic CD4+ cells (helper T cells) undergo clonal expansion, potentially leading to an abnormally elevated CD4/CD8 T-cell ratio in the peripheral blood, and a ratio less than 10 predicts a better response to treatment [22,23]. Here, CD8A is linked to synovial sarcoma.